Galectin-3 in Blood Serum and Lymphocytes as a Marker of Myocardial Damage in Patients with Arterial Hypertension and COVID-19.

Nataliia Pokrovska Nataliia Denysenko Iryna Fomenko Helen Sklyarova Andrii Basylevych Eugene Sklyarov Sandor G Vari Lesya Kobylinska

Published in: Anti-inflammatory & anti-allergy agents in medicinal chemistry (2024)

The level of galectin-3 in serum and lymphocytes was significantly higher in patients of both groups compared to the control group (p<0.05). Arterial hypertension causes structural changes in the cardiovascular system that are associated with elevated levels of galectin-3 in serum and lymphocytes. It can be used as a marker of myocardial damage in the context of arterial hypertension and COVID-19.

Keyphrases

arterial hypertension
coronavirus disease
sars cov
peripheral blood
end stage renal disease
left ventricular
oxidative stress
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
heart failure